Home
>
National Drug Code (NDC)
>
Silenor
Silenor - 42847-103-50 - (doxepin hydrochloride)
Drug Information of Silenor
| Product NDC: | 42847-103 |
| Proprietary Name: | Silenor |
| Non Proprietary Name: | doxepin hydrochloride |
| Active Ingredient(s): | 3 mg/1 & nbsp; doxepin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Silenor
| Product NDC: | 42847-103 |
| Labeler Name: | Somaxon Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022036 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100801 |
Package Information of Silenor
| Package NDC: | 42847-103-50 |
| Package Description: | 500 TABLET in 1 BOTTLE (42847-103-50) |
NDC Information of Silenor
| NDC Code | 42847-103-50 |
| Proprietary Name | Silenor |
| Package Description | 500 TABLET in 1 BOTTLE (42847-103-50) |
| Product NDC | 42847-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | doxepin hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100801 |
| Marketing Category Name | NDA |
| Labeler Name | Somaxon Pharmaceuticals, Inc. |
| Substance Name | DOXEPIN HYDROCHLORIDE |
| Strength Number | 3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Tricyclic Antidepressant [EPC] |
